![Mattis Ranthe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mattis F.
Ranthe served as the Chief Medical Officer at Expres2ion Biotech Holding AB from 2022 to 2023.
Prior to this, he obtained a doctorate degree from the University of Copenhagen in 2013.
Former positions of Mattis Ranthe
| Companies | Position | End |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Chief Tech/Sci/R&D Officer | 31/12/2023 |
Training of Mattis Ranthe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
- Stock Market
- Insiders
- Mattis Ranthe
